Space Research in Rome: A New Horizon for Pharmaceuticals
The National Laboratory of space Biomedicine at “Sapienza” University of Rome stands as a privileged observatory on the most advanced frontiers of medicine. As emphasized by its director, Professor Mariano Bizzarri, this center of excellence was born from a strategic synergy between the Roman university and Thales Alenia Space Italia. This collaboration gave rise to a true incubator of “numerous futuristic projects,” ranging from physiology to chemistry and bioengineering, with extraordinary potential applications in the field of space biomedicine.
Microgravity: The Key to Innovative Antibiotics and Advanced Therapies
In the Space Biomedicine Laboratory and at Thales Alenia, an incubator has been created to design new types of molecules in microgravity conditions—free of impurities and structural defects. As a result, they can be more effective and reduce many adverse effects.
The research focuses on developing new antibiotics produced exclusively by fungi under microgravity conditions, capable of overcoming current antimicrobial resistance.
Researchers are also studying complex molecules such as monoclonal antibodies, which can be synthesized with superior characteristics in the absence of gravity to treat diseases that are currently difficult to cure. As Professor Bizzarri states, the goal is to “fight diseases that are difficult or impossible to treat with current Earth-based therapies.”
Moreover, a valuable collaboration with the Space Factory agency in Naples will soon enable experiments in a recoverable satellite-laboratory. This opportunity is crucial for the “identification of molecules that cannot be synthesized on Earth, against which no microbe has developed resistance,” as Professor Bizzarri highlights—offering a response to the urgent issue of antibiotic ineffectiveness.
Pure Synthesis of Monoclonal Antibodies: Lower Costs and Fewer Side Effects
Space research enables scientists to overcome the limitations of Earth-based synthesis, producing monoclonal antibodies free of impurities and structural flaws. According to Professor Bizzarri, this “not only reduces production costs but also helps avoid many adverse effects.” The purity of molecules synthesized in space represents a significant therapeutic advancement.
New Strategies Against Cancer and the Study of Endocrine Disorders
Research in microgravity is revealing new mechanisms in the behavior of cancer cells, paving the way for more targeted and effective therapies. At the same time, studies such as OvoSpace aboard the International Space Station are analyzing the impact of microgravity on reproductive function, with potential implications for understanding and treating endocrine disorders such as polycystic ovary syndrome.
Diagnostic Innovation and Metabolic Prevention: Bringing the Benefits Back to Earth
Space research goes beyond drug development, offering the potential for advanced diagnostic tools and preventive strategies. For example, the Myo-Pasta project aims to leverage the knowledge gained to create functional foods to combat insulin resistance. As Professor Bizzarri concludes, this research “will also contribute to health and quality of life on our planet.”
Source: Ecostampa